Frontiers | Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
Moringa isothiocyanate-1 regulates Nrf2 and NF-κB pathway in response to LPS-driven sepsis and inflammation | PLOS ONE
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
Cells | Free Full-Text | Hypoxia Induced NF-κB
Hippocampal nuclear factor kappa B accounts for stress‐induced anxiety behaviors via enhancing neuronal nitric oxide synthase (nNOS)‐carboxy‐terminal PDZ ligand of nNOS‐Dexras1 coupling - Zhu - 2018 - Journal of Neurochemistry - Wiley
Frontiers | MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
What is NF-κB pathway? | MBInfo
Activation of the NF-kB transcription factors | Prof. David Wallach's Lab
The nuclear signaling of NF-κB: current knowledge, new insights, and future perspectives | Cell Research
NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type–Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve | Arteriosclerosis, Thrombosis, and Vascular Biology
nuclear factor kappa B signaling pathwayRat Genome Database
IJMS | Free Full-Text | NF-κB and Its Role in Checkpoint Control
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology: Trends in Molecular Medicine
Frontiers | NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases - ScienceDirect
The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease | SpringerLink
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
NF-kappa B signaling pathway - Cusabio
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
What is NF-κB pathway? | MBInfo
The role of nuclear factor kappa B in human labour in: Reproduction Volume 130 Issue 5 (2005)
NF-kB inhibitors and activators | Abcam
